Nippon Soda (4041) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
7 Aug, 2026Executive summary
Net sales rose 4.9% year-over-year to ¥34.25 billion in 1Q FY2027, with operating profit up 18.3% to ¥3.73 billion and ordinary profit up 23.2% to ¥5.58 billion.
Profit attributable to owners increased 2.0% to ¥3.28 billion; EPS grew 4.6% to ¥61.2.
Sales growth was driven by Agri Business and Trading & Logistics, offsetting declines in Chemical Materials.
Foreign exchange gains were recorded due to a weaker yen; extraordinary losses included costs from the Mizushima Plant closure.
Financial highlights
Net sales: ¥34.25B (+4.9% YoY); Operating profit: ¥3.73B (+18.3% YoY); Ordinary profit: ¥5.58B (+23.2% YoY).
Profit attributable to owners: ¥3.28B (+2.0% YoY); EPS: ¥61.2 (+4.6% YoY).
Exchange rates: JPY/USD 159.4 (+10.5%), JPY/EUR 185.5 (+13.2%).
Share of profit from equity-method entities slightly decreased by 2.9%.
Extraordinary losses from Mizushima Plant closure.
Outlook and guidance
Full-year FY2027 net sales forecast at ¥152.2B (+0.1% YoY); operating profit expected to decline 5.1% to ¥14.2B.
Profit attributable to owners forecast to decrease 13.5% to ¥15.8B; EPS expected at ¥294.8.
Inventory valuation gains in Agri Business expected to decrease; competitive pricing pressures anticipated.
R&D expenses to rise, especially for new insecticide registration.
No change to 1H forecast since May 2026; full-year forecast to be reviewed after 1H results.
Latest events from Nippon Soda
- Targets ¥20B+ net income by FY2030/3, driven by innovation, global growth, and sustainability.4041
Investor presentation14 May 2026 - Profit rose 21.7% and comprehensive income surged despite a 2.0% sales decline.4041
Q4 202614 May 2026 - Operating and ordinary profits rose despite lower sales, driven by Agri Business and equity gains.4041
Q3 202610 Mar 2026 - Sales and profits fell on Agri Business weakness, but full-year growth and a share split are forecast.4041
Q1 202510 Mar 2026 - Operating profit rose 9.6% YoY despite lower sales and a revised full-year outlook.4041
Q2 202510 Mar 2026 - Operating profit rose 15.8% but net and comprehensive income fell; FY2026 outlook is cautious.4041
Q4 202510 Mar 2026 - Profit rose on Chemical Materials and Engineering strength, but comprehensive income dropped sharply.4041
Q3 202510 Mar 2026 - Flat sales and profit, but strong profit growth and a positive FY2026 outlook.4041
Q2 202610 Mar 2026 - Sales and operating profit rose, but net income dropped 25.9% on forex losses.4041
Q1 202610 Mar 2026